CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma

Emergent BioSolutions

Status and phase: Terminated; Phase 2

Conditions: T-cell Lymphoma

Treatments: Biological: CHOP + CD4; Drug: CHOP

Study type: Interventional

Funder types: Industry

Identifiers

NCT00893516

GEN112

Details and patient eligibility

About

Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.

Enrollment: 5 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• study is closed to enrollment

Exclusion criteria

• study is closed to enrollment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

5 participants in 2 patient groups

1

Experimental group

Description:

CHOP chemo therapy + CD4 therapy

Treatment:

Biological: CHOP + CD4

2

Active Comparator group

Description:

CHOP chemotherapy

Treatment:

Drug: CHOP